Kenvue, a two-year-old spinoff from Johnson & Johnson, is confronting a public-relations nightmare as President Trump and others suggest unproven links between the pain reliever and autism.
from NYT > Health https://ift.tt/8t59VsX
Check out
Subscribe to:
Post Comments (Atom)
$2.5 Million Rift Pits Cannabis Pioneer Against Group That Backed Her
A dispute between the nonprofit Housing Works and the owner of a cannabis dispensary shows the risks for businesses in an industry that is l...
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing...
-
Captive animals sometimes need a transfusion, but the typical approach to blood banking isn’t practical for zoos and aquariums. One veterina...
-
The health secretary said he would prioritize studies into environmental causes while harshly discounting other factors scientists say are l...
No comments:
Post a Comment